PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383390
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383390
Elisa Tests Market Forecasts to 2030 - Global Analysis By Type (Indirect ELISA, Sandwich ELISA, Competitive ELISA and Multiple and Portable ELISA), Technology (Chemiluminescent, Colorimetric and Fluorescent), Application, End User and By Geography
According to Stratistics MRC, the Global Elisa Tests Market is accounted for $2.55 billion in 2023 and is expected to reach $4.64 billion by 2030 growing at a CAGR of 8.9% during the forecast period. The enzyme-linked immune sorbent assay is the standard assay technique used to identify and quantify antibodies, hormones, peptides, and proteins in the blood. The ELISA test is often used in pharmaceutical quality control tests like endotoxin assays and protein quantification and is crucial in the diagnosis of a number of viral diseases. ELISA is a diagnostic technique in plant pathology and medicine as well as a quality control checks in many different sectors. Enzyme-linked immune sorbent assay (ELISA) testing is frequently used as a quality assurance check and screening instrument in a variety of fields, including medicine and plant pathology.
According to the World Health Organization (WHO), around 37.7 million people had HIV in 2020.
Market Dynamics:
Driver:
Rising demand for early and accurate diagnosis
Effective illness management and therapy rely on early and precise diagnosis. The high sensitivity and specificity of Elisa testing enable medical personnel to identify and measure particular biomarkers in patient samples. Early diagnosis enables quick treatment beginning, which can greatly enhance patient results. Additionally, healthcare practitioners can intervene and swiftly implement effective treatment techniques by quickly recognizing these biomarkers. The market for Elisa testing is expanding due to the demand for early and accurate diagnosis.
Restraint:
Stringent government regulations
The marketing of diagnostic products is difficult because some products are categorized as medical devices even though they are intended for use in diagnostic procedures by doctors. Without successfully completing clinical trials, which are a time-consuming, expensive, and uncertain process, such devices cannot be launched. The reality that different countries have different rules for these devices' certification is a significant challenge for international corporations. Additionally, any modifications to rules made by various regulatory agencies, like the FDA, during the product development process may cause a delay in the introduction of potential products. These stringent government regulations are the major barriers to market growth.
Opportunity:
Technological developments
The market for Elisa testing has benefited from technological developments such as the creation of automated systems, the ability to multiplex and enhanced sensitivity and specificity of assays. Technological improvements have led to the creation of automated Elisa systems, excluding manual labor and enhancing efficiency. Multiple samples can be handled simultaneously by automated platforms, streamlining the testing procedure and boosting throughput. Furthermore, by speeding up turnaround times and increasing laboratory efficiency, this technology enables healthcare practitioners to efficiently perform a higher volume of tests. Elisa tests are becoming more widely used in many healthcare settings as a result of these developments, which improve their effectiveness, accuracy, and productivity, which drives market demand.
Threat:
Alternative technologies' competition
Alternative diagnostic technologies, such as point-of-care testing (POCT) devices, next-generation sequencing (NGS), and molecular diagnostic techniques (e.g., PCR), compete with Elisa tests on the market. These innovations have benefits like quicker turnaround times, greater sensitivity, and the capacity to detect multiple analytes at once. Elisa tests may be replaced or competed with as these technologies develop and become more widely available, especially in areas where molecular diagnostics have clear advantages. The market for Elisa tests may be threatened by the availability and uptake of these substitute technologies.
COVID-19 Impact
Initially, in the COVID-19 epidemic, there were no particular diagnostic tests available to identify the illness in patients. Initially, alternative diagnostic procedures were attempted, but they were not very successful. Additionally, due to the unavailability of certain COVID-19 diagnostic tests, diagnostic kit manufacturers had profitable chances to market their COVID-19 diagnostic products. Utilizing this chance, many established companies as well as a few start-ups from different nations offered COVID-19 diagnostic kits to local as well as global markets.
The sandwich ELISA segment is expected to be the largest during the forecast period
The sandwich ELISA segment is estimated to hold the largest share. Antigen is measured using a sandwich ELISA, which consists of two layers of antibodies (the capture antibody and the detection antibody). Two antigenic sites on the target antigens are ready to bind to the antibodies. In sandwich ELISA techniques, monoclonal or polyclonal antibodies are employed to capture and recognize antibodies. Sandwich ELISA works the best for detecting immunological responses, and this fact is promoting market expansion. Sandwich ELISA, which uses a variety of antibodies to bind to the same antigen for recognition or detection, is also the most sensitive test available. It also has a high degree of flexibility and higher specificity.
The infectious diseases segment is expected to have the highest CAGR during the forecast period
The infectious diseases segment is anticipated to have lucrative growth during the forecast period, due to an increase in the prevalence of chronic illnesses and infectious disorders, infectious diseases are now leading the ELISA market's application sector. HIV, HBV, HCV, HTLV, Diphtheria, Giardiasis, and several other infectious blood-borne illnesses The application sector of the enzyme-linked immune sorbent assay (ELISA) testing market is dominated by ELISA tests because they provide quick and accurate findings, have high sensitivity, are automated and simple to perform, and do not require radioactive materials or expensive radiation gear.
Region with largest share:
North America commanded the largest market share during the extrapolated period due to the highly developed healthcare system and the growing use of medical gadgets. Rising R&D expenditures by pharmaceutical firms and government organizations for disorders and diseases, including diabetes and chronic illnesses, would also contribute to the market growth for ELISA tests in this region during the projected period.
Region with highest CAGR:
Europe is expected to witness profitable growth over the projection period due to the rising disposable income and healthcare expenditure in emerging nations. The market for ELISA tests is anticipated to grow in the coming years as a result of the rising use of medical equipment in developed nations. Additionally, due to the large geriatric population and significant investment in research and development, in the projected time frame, it is also anticipated that the rising frequency of non-communicable diseases on the European continent will increase demand for ELISA testing.
Key players in the market
Some of the key players in the Elisa Tests Market include: Abbott Laboratories, Danaher Corporation, BioMerieux SA, Quidel Corporation, Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., ZEUS Scientific, Inc., Hoffmann-La Roche AG, PerkinElmer, Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., R&D Systems, Inc., Bruker, Eurofins Scientific, ELISA Technologies, Inc and BioLegend, Inc.
Key Developments:
In May 2023, Abbott, a global leader in health care and nutrition, has partnered with Real Madrid, one of the most successful and popular football clubs in the world, to inaugurate the Abbott-Real Madrid Innovation Lab, a space for collaboration and research on the future of sports physiology and nutrition.
In March 2023, Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.
In November 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test.
Types Covered:
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
- Multiple and Portable ELISA
Technologies Covered:
- Chemiluminescent
- Colorimetric
- Fluorescent
Applications Covered:
- Infectious Diseases
- Protein Quantitation
- Vaccine Development
- Cancer
- Immunology
- Other Applications
End Users Covered:
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Clinical Laboratories
- Hospitals and Diagnostic Centers
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 TechnologyAnalysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Elisa Tests Market, By Type
- 5.1 Introduction
- 5.2 Indirect ELISA
- 5.3 Sandwich ELISA
- 5.4 Competitive ELISA
- 5.5 Multiple and Portable ELISA
6 Global Elisa Tests Market, By Technology
- 6.1 Introduction
- 6.2 Chemiluminescent
- 6.3 Colorimetric
- 6.4 Fluorescent
7 Global Elisa Tests Market, By Application
- 7.1 Introduction
- 7.2 Infectious Diseases
- 7.3 Protein Quantitation
- 7.4 Vaccine Development
- 7.5 Cancer
- 7.6 Immunology
- 7.7 Other Applications
8 Global Elisa Tests Market, By End User
- 8.1 Introduction
- 8.2 Pharmaceutical and Biotech Companies
- 8.3 Academic Research Centers
- 8.4 Clinical Laboratories
- 8.5 Hospitals and Diagnostic Centers
- 8.6 Other End Users
9 Global Elisa Tests Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Abbott Laboratories
- 11.2 Danaher Corporation
- 11.3 BioMerieux SA
- 11.4 Quidel Corporation
- 11.5 Siemens Healthineers
- 11.6 Sysmex Corporation
- 11.7 Bio-Rad Laboratories
- 11.8 Ortho Clinical Diagnostics
- 11.9 Thermo Fisher Scientific, Inc.
- 11.10 ZEUS Scientific, Inc.
- 11.11 Hoffmann-La Roche AG
- 11.12 PerkinElmer, Inc.
- 11.13 Enzo Life Sciences, Inc.
- 11.14 Agilent Technologies, Inc.
- 11.15 R&D Systems, Inc.
- 11.16 Bruker
- 11.17 Eurofins Scientific
- 11.18 ELISA Technologies, Inc
- 11.19 BioLegend, Inc
List of Tables
- Table 1 Global Elisa Tests Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 3 Global Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 4 Global Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 5 Global Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 6 Global Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 7 Global Elisa Tests Market Outlook, By Technology(2021-2030) ($MN)
- Table 8 Global Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 9 Global Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 10 Global Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 11 Global Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 12 Global Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 13 Global Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 14 Global Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 15 Global Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 16 Global Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 17 Global Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 18 Global Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 19 Global Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 20 Global Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 21 Global Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 22 Global Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 23 Global Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 24 North America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 25 North America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 26 North America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 27 North America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 28 North America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 29 North America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 30 North America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
- Table 31 North America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 32 North America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 33 North America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 34 North America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 35 North America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 36 North America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 37 North America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 38 North America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 39 North America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 40 North America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 41 North America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 42 North America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 43 North America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 44 North America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 45 North America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 46 North America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 47 Europe Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 48 Europe Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 49 Europe Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 50 Europe Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 51 Europe Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 52 Europe Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 53 Europe Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
- Table 54 Europe Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 55 Europe Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 56 Europe Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 57 Europe Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 58 Europe Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 59 Europe Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 60 Europe Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 61 Europe Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 62 Europe Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 63 Europe Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 64 Europe Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 65 Europe Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 66 Europe Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 67 Europe Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 68 Europe Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 69 Europe Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 70 Asia Pacific Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 71 Asia Pacific Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 72 Asia Pacific Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 73 Asia Pacific Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 74 Asia Pacific Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 75 Asia Pacific Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 76 Asia Pacific Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
- Table 77 Asia Pacific Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 78 Asia Pacific Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 79 Asia Pacific Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 80 Asia Pacific Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 81 Asia Pacific Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 82 Asia Pacific Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 83 Asia Pacific Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 84 Asia Pacific Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 85 Asia Pacific Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 86 Asia Pacific Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 87 Asia Pacific Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 88 Asia Pacific Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 89 Asia Pacific Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 90 Asia Pacific Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 91 Asia Pacific Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 92 Asia Pacific Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 93 South America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 94 South America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 95 South America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 96 South America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 97 South America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 98 South America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 99 South America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
- Table 100 South America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 101 South America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 102 South America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 103 South America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 104 South America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 105 South America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 106 South America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 107 South America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 108 South America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 109 South America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 110 South America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 111 South America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 112 South America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 113 South America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 114 South America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 115 South America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 116 Middle East & Africa Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 117 Middle East & Africa Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
- Table 118 Middle East & Africa Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
- Table 119 Middle East & Africa Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
- Table 120 Middle East & Africa Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
- Table 121 Middle East & Africa Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
- Table 122 Middle East & Africa Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
- Table 123 Middle East & Africa Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
- Table 124 Middle East & Africa Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
- Table 125 Middle East & Africa Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
- Table 126 Middle East & Africa Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
- Table 127 Middle East & Africa Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
- Table 128 Middle East & Africa Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
- Table 129 Middle East & Africa Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
- Table 130 Middle East & Africa Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
- Table 131 Middle East & Africa Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
- Table 132 Middle East & Africa Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 133 Middle East & Africa Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 134 Middle East & Africa Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
- Table 135 Middle East & Africa Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
- Table 136 Middle East & Africa Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
- Table 137 Middle East & Africa Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
- Table 138 Middle East & Africa Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
